Sontag Advisory »

Outlook Therapeutics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $318 300 1.06

More positions owned by Sontag Advisory

iShares Core S&P 500 ETF Etf (IVV)
Vanguard MSCI EAFE ETF Etf (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Etf (IJH)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab International Equity ETF Etf (SCHF)
Vanguard FTSE Emerging Markets ETF Etf (VWO)
Vanguard Index Fds Growth Etf (VUG)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Extended Market ETF Etf (VXF)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Sontag Advisory

Top funds holding Outlook Therapeutics

Vanguard Group
Schonfeld Strategic Advisors
Morgan Stanley
BlackRock
Geode Capital Management
Susquehanna International
Millennium Management
Commonwealth Equity Services
Simplex Trading
State Street Corporation
Scotia Capital
LVW Advisors
UBS Group
Citadel Advisors
Goldman Sachs Group

View all funds holding Outlook Therapeutics